Tanja Denise DE GRUIJL

Person

Amsterdam, NL

People

Patents Grantslast 30 patents

Information Patent Grant
Single domain antibodies targeting CD1d
- Patent number 12,110,328
- Issue date Oct 8, 2024
- LAVA THERAPEUTICS N.V.
- Johannes Jelle Van Der Vliet
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies for use in the treatment of hematological mal...
- Patent number 12,077,586
- Issue date Sep 3, 2024
- LAVA THERAPEUTICS N.V.
- Iris De Weerdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single domain antibodies targeting CD1d
- Patent number 11,591,394
- Issue date Feb 28, 2023
- LAVA THERAPEUTICS N.V.
- Johannes Jelle Van Der Vliet
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoglobulins binding human Vγ9Vδ2 T cell receptors
- Patent number 11,384,145
- Issue date Jul 12, 2022
- LAVA THERAPEUTICS N.V.
- Johannes Jelle Van Der Vliet
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single domain antibodies targeting CD1d
- Patent number 10,501,541
- Issue date Dec 10, 2019
- LAVA THERAPEUTICS B.V.
- Johannes Jelle Van Der Vliet
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoglobulins binding human Vγ9 Vδ2 T cell receptors
- Patent number 10,501,540
- Issue date Dec 10, 2019
- LAVA Therapeutics B.V.
- Johannes Jelle Van Der Vliet
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for inducing and accelerating cells
- Patent number 8,470,789
- Issue date Jun 25, 2013
- DCPrime B.V.
- Sandra van Wetering
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
SINGLE DOMAIN ANTIBODIES TARGETING CD1D
- Publication number 20240425592
- Publication date Dec 26, 2024
- LAVA THERAPEUTICS N.V.
- Johannes Jelle VAN DER VLIET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE DOMAIN ANTIBODIES TARGETING CD1D
- Publication number 20240067726
- Publication date Feb 29, 2024
- LAVA THERAPEUTICS N.V.
- Johannes Jelle VAN DER VLIET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOGLOBULINS BINDING HUMAN VGAMMA9VDELTA2 T CELL RECEPTORS
- Publication number 20230212290
- Publication date Jul 6, 2023
- LAVA THERAPEUTICS N.V.
- Johannes Jelle Van Der Vliet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CD40-BINDING ANTIBODIES
- Publication number 20220135694
- Publication date May 5, 2022
- LAVA THERAPEUTICS B.V.
- Johannes Jelle VAN DER VLIET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL ACTING CD1D IMMUNOGLOBULIN
- Publication number 20220111043
- Publication date Apr 14, 2022
- LAVA THERAPEUTICS B.V.
- Johannes Jelle VAN DER VLIET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOGLOBULINS BINDING HUMAN VGAMMA9VDELTA2 T CELL RECEPTORS
- Publication number 20220098301
- Publication date Mar 31, 2022
- LAVA THERAPEUTICS N.V.
- Johannes Jelle VAN DER VLIET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL BISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF HEMATOLOGIC...
- Publication number 20210371525
- Publication date Dec 2, 2021
- LAVA THERAPEUTICS B.V.
- Iris DE WEERDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE DOMAIN ANTIBODIES TARGETING CD1D
- Publication number 20200115450
- Publication date Apr 16, 2020
- LAVA THERAPEUTICS B.V.
- Johannes Jelle VAN DER VLIET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE DOMAIN ANTIBODIES TARGETING CD1D
- Publication number 20180142020
- Publication date May 24, 2018
- LAVA THERAPEUTICS B.V.
- Johannes Jelle VAN DER VLIET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immunoglobulins Binding Human Vgamma9 Vdelta2 T Cell Receptors
- Publication number 20170029506
- Publication date Feb 2, 2017
- Stichting VUmc
- Johannes Jelle VAN DER VLIET
- C07 - ORGANIC CHEMISTRY

Tanja Denise DE GRUIJL

Person

Patents Grantslast 30 patents

Single domain antibodies targeting CD1d

Bispecific antibodies for use in the treatment of hematological mal...

Single domain antibodies targeting CD1d

Immunoglobulins binding human Vγ9Vδ2 T cell receptors

Single domain antibodies targeting CD1d

Immunoglobulins binding human Vγ9 Vδ2 T cell receptors

Method for inducing and accelerating cells

Patents Applicationslast 30 patents

SINGLE DOMAIN ANTIBODIES TARGETING CD1D

SINGLE DOMAIN ANTIBODIES TARGETING CD1D

IMMUNOGLOBULINS BINDING HUMAN VGAMMA9VDELTA2 T CELL RECEPTORS

NOVEL CD40-BINDING ANTIBODIES

DUAL ACTING CD1D IMMUNOGLOBULIN

IMMUNOGLOBULINS BINDING HUMAN VGAMMA9VDELTA2 T CELL RECEPTORS

NOVEL BISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF HEMATOLOGIC...

SINGLE DOMAIN ANTIBODIES TARGETING CD1D

SINGLE DOMAIN ANTIBODIES TARGETING CD1D

Immunoglobulins Binding Human Vgamma9 Vdelta2 T Cell Receptors